Industry

YC Therapeutics Companies

90 Y Combinator therapeutics startups with verified founder contacts, batch info, and company data.

Companies

Active

Acquired

Public

YC Company Directory

50 companies

Export All

Company	Batch	Description	Status	Location	Team	Founders	Reveal
FinalDose	X26	Programmable DNA drug destroying all cancers, unlocking 80% of targets	Active	London, England, United Kingdom	5	Li-Yao Huang, Steven Lin, Jeff Liu	Reveal
Exin Therapeutics	W25	AI drug discovery platform for neurotherapeutics	Active	San Francisco, CA, USA	9	Gabriel Ocana Santero, Marko Tvrdic, Gabriel Ocana Santero	Reveal
Exin Therapeutics	W25	AI drug discovery platform for neurotherapeutics	Active	San Francisco, CA, USA	3	Gabriel Ocana Santero, Ivan Lazarte, Marko Tvrdic	Reveal
Uncommon Therapeutics	W25	A Disease Focused Biotech, Building Multiple Billion Dollar Drugs	Active	San Francisco, CA, USA	2	Noah Auerhahn, Ryan Lim	Reveal
Eris Biotech	W24	Our drugs engage the immune system to fight tumors	Active	Lehi, UT, USA	2	Rachel Garlick, Evita Weagel	Reveal
Eris Biotech	W24	Our drugs engage the immune system to fight tumors	Active	Lehi, UT, USA	2	Rachel Garlick, Evita Weagel	Reveal
Granza Bio	W24	Building programmable therapeutics for the immune system	Active	San Francisco, CA, USA	8	Ashwin Nandakumar, Ashwin Jainarayanan	Reveal
Granza Bio	W24	Reprogramming Immunity for Target-Specific Medicines	Active	San Francisco, CA, USA	7	Ashwin Nandakumar, Ashwin Jainarayanan	Reveal
Junction Bioscience	W24	AI Hypothesis Engine for Molecular Discovery	Active	New York City, NY, USA	—	Brian Petkov	Reveal
Junction Bioscience	W24	AI Hypothesis Engine for Molecular Discovery	Active	—	1	Brian Petkov	Reveal
ParcelBio	W24	Elevated mRNA for transformative medicines.	Active	San Francisco, CA, USA	6	David Weinberg, Chris Carlson, Christopher Carlson	Reveal
SynsoryBio	W24	"If-then" conditional logic for protein drugs	Active	Cambridge, MA, USA	2	Elliot Tague, Nathan Tague	Reveal
SynsoryBio	W24	"If-then" conditional logic for protein drugs	Active	Boston, MA, USA	2	Elliot Tague, Nathan Tague	Reveal
Velorum Therapeutics	W24	Breakthrough medicines unlocking the biology of heme	Active	San Francisco, CA, USA	5	Pouya Modareszadeh, Parsa Modareszadeh	Reveal
Velorum Therapeutics	W24	Breakthrough medicines unlocking the biology of heme	Active	San Francisco, CA, USA	5	Pouya Modareszadeh, Parsa Modareszadeh	Reveal
Modulari-T	W23	We teach your immune system to attack and cure cancer	Active	Montreal, QC, Canada; San Francisco, CA, USA	4	David White, Stephanie Mok, David Cotnoir-White	Reveal
Alixia	W22	Targeting the Tumor Ecosystem to address cancer drug resistance.	Active	San Francisco, CA, USA	2	Olof Mollstedt, Helen Chen	Reveal
Alixia	W22	Targeting the Tumor Ecosystem to address cancer drug resistance.	Active	San Francisco, CA, USA	2	Olof Mollstedt, Helen Chen	Reveal
Engage Bio	W22	Potent, durable, and redosable non-viral genetic medicines	Acquired	San Francisco, CA, USA	10	Will Olsen, Kathryn Kwant	Reveal
Origami Therapeutics, Inc.	W22	Oral drugs to halt neurodegeneration	Active	San Diego, CA, USA	4	Beth Hoffman	Reveal
Biodock	W21	Cloud AI microscopy automation	Active	Austin, TX, USA	8	Nurlybek Mursaliyev, Michael Lee	Reveal
Biodock	W21	Cloud AI microscopy automation	Active	Austin, TX, USA	8	Nurlybek Mursaliyev	Reveal
Entelexo Biotherapeutics	W21	Creating a New Class of Drugs to Address Incurable Autoimmune Diseases	Active	Irvine, CA, USA	3	MILAD RIAZIFAR, Todd Schurr, Cameron Taylor	Reveal
Nuntius Therapeutics	W21	Cell-specific genetic medicines	Active	London, UK	2	Benita Nagel, Albert Kwok	Reveal
PipeBio	W21	PipeBio is a SaaS bioinformatics platform to develop antibody drugs.	Acquired	Aarhus, Denmark	10	Owen Bodley, Jannick Bendtsen	Reveal
Serna Bio	W21	Genetic Medicine with Small Molecules	Active	Ontario, CA, USA	5	Rabia Khan	Reveal
Valink Therapeutics	W21	Discovering bispecific antibody drug-conjugates (BsADC) against cancer	Active	Boston, MA, USA	15	Arne Scheu, Irsyad Khairil	Reveal
Valink Therapeutics	W21	Discovering bispecific antibody drug-conjugates (BsADC) against cancer	Active	Boston, MA, USA	15	Arne Scheu, Irsyad Khairil	Reveal
WonderTx	S26	Extrapolative AI to unlock First-in-Class drugs	Active	San Francisco, CA, USA; Remote	3	Abraham Heifets	Reveal
Blank Bio	S25	RNA intelligence for precision medicine	Active	San Francisco, CA, USA	6	Jonny Hsu, Philip Fradkin, Ian Shi	Reveal
Evolvere BioSciences	S24	Making Next-Generation Antibiotics that Outpace Bacterial Evolution	Active	Oxford, England, United Kingdom	3	Adam Winnifrith, Piotr Jedryszek, Weronika Slesak	Reveal
Evolvere BioSciences	S24	Making Next-Generation Antibiotics that Outpace Bacterial Evolution	Active	Oxford, UK	3	Adam Winnifrith, Piotr Jedryszek, Weronika Slesak	Reveal
Kopra Bio	S24	Genetically engineered viruses that teach your immune system to kill…	Active	San Francisco, CA, USA	2	Alexander Haddad, Andrew Bartynski	Reveal
Eugit Therapeutics	S22	Enabling Tissue Targeting of Therapies	Active	San Carlos, CA, USA	2	Nizar Batada	Reveal
Eugit Therapeutics	S22	Enabling Tissue Targeting of Therapies	Active	San Francisco, CA, USA; South San Francisco, CA, USA	2	Nizar Batada, George Church	Reveal
Guardian Bio	S22	Dendritic cell-based platform for cancer therapy	Active	Boston, MA, USA	2	Ananya Zutshi, Ricky Barrett	Reveal
Guardian Bio	S22	Dendritic cell-based platform for cancer therapy	Active	Boston, MA, USA	2	Ananya Zutshi, Ricky Barrett	Reveal
Keylika	S22	Redefining the Standard of Care for Iron Deficiency Anemia	Active	Walnut Creek, CA, USA	1	Buddha Chaudhuri, Frederik Ceyssens	Reveal
Keylika	S22	Redefining the Standard of Care for Iron Deficiency Anemia	Active	San Francisco, CA, USA; Walnut Creek, CA, USA	1	Buddha Chaudhuri, Frederik Ceyssens	Reveal
Relevium Medical	S22	Platform injectable gel based therapeutic for osteoarthritis	Active	Galway, County Galway, Ireland	5	Alison Liddy	Reveal
Serinus Biosciences	S22	Combinations therapy by rational design	Active	New York City, NY, USA; New York, NY, USA	6	Adam Yaari, Maxwell Sherman	Reveal
Serinus Biosciences	S22	Combinations therapy by rational design	Active	New York, NY, USA	6	Adam Yaari, Maxwell Sherman	Reveal
Catena Biosciences	S21	Using protein coupling to build new therapies	Active	San Francisco, CA, USA; Berkeley, CA, USA	7	Marco Lobba, Matthew Francis, Gregorio Guillen	Reveal
Catena Biosciences	S21	Using protein coupling to build new therapies	Active	Berkeley, CA, USA	7	Marco Lobba, Matthew Francis	Reveal
Humane Genomics	S21	A platform to make artificial viruses as cancer therapeutics.	Active	New York City, NY, USA; New York, NY, USA	5	Peter Weijmarshausen, Chad Moles	Reveal
Inflow	S21	A self-help app for people to manage their ADHD.	Acquired	London, England, United Kingdom; New York, NY, USA	20	Levi Epstein, Seb Isaacs, George Sachs	Reveal
Medium Biosciences	S21	AI-designed Protein Therapeutics	Active	San Francisco, CA, USA	6	Adil Yusuf, Mohamed Hassan Kane	Reveal
Promakhos Therapeutics	S21	A therapeutics platform for curing inflammatory disorders	Active	Boston, MA, USA	2	Katerina Chatzi, Jasper Edgar Neggers	Reveal
Promakhos Therapeutics	S21	A therapeutics platform for curing inflammatory disorders	Active	Boston, MA, USA	2	Katerina Chatzi, Jasper Edgar Neggers	Reveal
Sensible Biotechnologies	S21	Unlocking the next generation of mRNA medicines	Active	Oxford, England, United Kingdom	24	Miroslav Gasparek, Marian Kupculak	Reveal

Batch Distribution

XX261 WW253 WW2411 WW231 WW224 WW218

Status Breakdown

Active80 Inactive6 Acquired4

Top Locations

San Francisco32 Boston10 London4 Oxford4 San Carlos4 New York City3

About YC Therapeutics Companies

Y Combinator has funded 90 therapeutics companies since its founding in 2005. These startups span from early-stage pre-launch to publicly traded companies, making YC one of the most prolific backers of therapeutics innovation globally.

80 of these companies are currently active. 4 have been acquired. VCBacked tracks verified founder contact information, team sizes, and company status for every YC therapeutics startup.

Related Industries

B2B3278 Healthcare805 Fintech709 Consumer654 Engineering, Product and Design610 Industrials489 Infrastructure303 Productivity208

← All YC Companies

Get the full therapeutics dataset

Verified founder emails, CSV export, and advanced filters for all 90 YC therapeutics companies.

No credit card required